Avadel Pharmaceuticals plc
AVDL
$14.20
$0.201.43%
NASDAQ
| 06/30/2025 | 03/31/2025 | 12/31/2024 | 09/30/2024 | 06/30/2024 | |
|---|---|---|---|---|---|
| Net Income | 169.92% | 82.01% | 82.48% | 92.76% | 78.55% |
| Total Depreciation and Amortization | 144.39% | 52.50% | 3,811.11% | 73.95% | -27.29% |
| Total Amortization of Deferred Charges | -- | -- | -- | -- | -- |
| Total Other Non-Cash Items | -10.09% | -8.93% | -15.19% | 103.44% | -76.11% |
| Change in Net Operating Assets | 74.35% | -10.79% | 281.40% | -93.38% | -193.94% |
| Cash from Operations | 169.82% | 72.29% | 128.09% | 81.98% | 43.21% |
| Capital Expenditure | -- | -- | -- | -- | -- |
| Sale of Property, Plant, and Equipment | -- | -- | -- | -- | -- |
| Cash Acquisitions | -- | -- | -- | -- | -- |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | -176.52% | -42.41% | -46.60% | -49.80% | 111.36% |
| Cash from Investing | -178.24% | -42.41% | -46.60% | -49.80% | 111.36% |
| Total Debt Issued | -- | -- | -- | -- | -- |
| Total Debt Repaid | -- | -- | -- | -- | -- |
| Issuance of Common Stock | 35.82% | -94.77% | 1,529.63% | 155.87% | -99.47% |
| Repurchase of Common Stock | -- | -- | -- | -- | -- |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | -- | -- | -- | -- | -- |
| Cash from Financing | 35.82% | -94.77% | 104.17% | -96.14% | -99.21% |
| Foreign Exchange rate Adjustments | 4,826.47% | 191.06% | -254.40% | 326.20% | -78.95% |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | 201.22% | 8.04% | 210.39% | -114.51% | 79.20% |